Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Director departure
Appointed director
BIONOVO INC (BNVI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/01/2012 8-K Quarterly results
05/25/2012 8-K Other Events
05/08/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/27/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/12/2012 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Form of Warrant",
"Securities Purchase Agreement",
"Bionovo Enters Into Agreement for Offering of Common Stock and Warrants EMERYVILLE, Calif. – March 12, 2012 — Bionovo, Inc. On March 12, 2012, Bionovo, Inc., entered into a securities purchase agreement with investors to purchase an aggregate of 14,231,696 shares of our common stock, par value $0.0001 per share . The aggregate purchase price for the Common Shares is approximately $426,951. Additionally, each Investor will receive a warrant exercisable into shares of our common stock. The Warrants shall be exercisable into an aggregate of 11,485,844 shares of our common stock at an exercise price of $0.03 per share. The Warrants expire on March 30, 2012. If the Warrants are exercised in full for cash, the Company will receive approximately an additional $344,575 in proceeds. The Common Shar..."
03/01/2012 8-K Termination of a Material Definitive Agreement
02/17/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Order Approving Stipulation for Settlement of Claim",
"Stipulation for Settlement of Claim"
01/27/2012 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "Amended and Restated Employment Agreement between Bionovo, Inc. and Isaac Cohen",
"Amended and Restated Employment Agreement between Bionovo, Inc. and Mary Tagliaferri",
"Bionovo to Voluntarily Delist from NASDAQ"
01/06/2012 8-K Form 8-K - Current report
11/10/2011 8-K Form 8-K - Current report
09/19/2011 8-K Form 8-K - Current report
08/30/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Bionovo Announces Positive Results of the Tolerability Trial of Menerba for Menopausal Hot Flashes Greater Efficacy Observed with Higher Doses EMERYVILLE, Calif. – August 30, 2011 — Bionovo, Inc. , a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the positive results from the completion of their tolerability trial of MenerbaTM for menopausal hot flashes. The open-label, randomized, clinical trial of Menerba was conducted at four U.S. clinical sites. Postmenopausal women between the ages of 40 and 65 years were randomized to one of two doses of Menerba and treated for 28 days. The primary goal of the study was to assess the safety and tolerability of two doses of Menerba, higher than those previ..."
05/13/2011 8-K Form 8-K - Current report
05/11/2011 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Bionovo Announces First Quarter 2011 Highlights and Financial Results"
03/15/2011 8-K Form 8-K - Current report
02/02/2011 8-K Form 8-K - Current report
11/12/2010 8-K Form 8-K - Current report
10/04/2010 8-K Form 8-K - Current report
09/27/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Approves Manufacturing Plan for Menerba, Bionovo's Menopausal Hot Flash Drug Candidate"
08/31/2010 8-K Form 8-K - Current report
08/04/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Bionovo Announces Second Quarter 2010 Highlights and Financial Results"
05/11/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Bionovo Announces First Quarter 2010 Highlights and Financial Results"
05/05/2010 8-K Submission of Matters to a Vote of Security Holders
04/28/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Bionovo to Hold Annual Shareholder Meeting May 3, 2010"
03/19/2010 8-K Form 8-K - Current report
03/15/2010 8-K Quarterly results
Docs: "[email protected]"
11/05/2009 8-K Form 8-K - Current report
09/21/2009 8-K Form 8-K - Current report
08/10/2009 8-K Form 8-K - Current report
05/07/2009 8-K Form 8-K -- Current report
03/12/2009 8-K Form 8-K -- Current report
12/03/2008 8-K Form 8-K -- Current report
11/04/2008 8-K Quarterly results
Docs: "EX99.1"
10/20/2008 8-K Regulation FD Disclosure
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy